BR112022024233A2 - Composição de tratamento renal usando omento, kit médico de tratamento renal que compreende a mesma e filme de tratamento renal que compreende produto curado da mesma - Google Patents
Composição de tratamento renal usando omento, kit médico de tratamento renal que compreende a mesma e filme de tratamento renal que compreende produto curado da mesmaInfo
- Publication number
- BR112022024233A2 BR112022024233A2 BR112022024233A BR112022024233A BR112022024233A2 BR 112022024233 A2 BR112022024233 A2 BR 112022024233A2 BR 112022024233 A BR112022024233 A BR 112022024233A BR 112022024233 A BR112022024233 A BR 112022024233A BR 112022024233 A2 BR112022024233 A2 BR 112022024233A2
- Authority
- BR
- Brazil
- Prior art keywords
- kidney treatment
- same
- kidney
- omentum
- cured product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
Abstract
COMPOSIÇÃO DE TRATAMENTO RENAL USANDO OMENTO, KIT MÉDICO DE TRATAMENTO RENAL QUE COMPREENDE A MESMA E FILME DE TRATAMENTO RENAL QUE COMPREENDE PRODUTO CURADO DA MESMA. A presente invenção se refere a uma composição de tratamento renal usando omento, um kit médico de tratamento renal que compreende a composição de tratamento renal usando omento e um filme de tratamento renal que compreende o produto curado da composição de tratamento renal usando omento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200065439 | 2020-05-29 | ||
KR1020210046267A KR102311441B1 (ko) | 2020-05-29 | 2021-04-09 | 그물막을 이용한 신장 치료용 조성물, 이를 포함하는 신장 치료용 의료 키트, 및 이의 경화물을 포함하는 신장 치료용 필름 |
PCT/KR2021/004497 WO2021241880A1 (ko) | 2020-05-29 | 2021-04-09 | 그물막을 이용한 신장 치료용 조성물, 이를 포함하는 신장 치료용 의료 키트, 및 이의 경화물을 포함하는 신장 치료용 필름 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022024233A2 true BR112022024233A2 (pt) | 2022-12-27 |
Family
ID=78150707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022024233A BR112022024233A2 (pt) | 2020-05-29 | 2021-04-09 | Composição de tratamento renal usando omento, kit médico de tratamento renal que compreende a mesma e filme de tratamento renal que compreende produto curado da mesma |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230072749A1 (pt) |
EP (1) | EP3998090A4 (pt) |
JP (1) | JP2023527435A (pt) |
KR (2) | KR102311441B1 (pt) |
CN (1) | CN114258304A (pt) |
BR (1) | BR112022024233A2 (pt) |
WO (1) | WO2021241880A1 (pt) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10064948C1 (de) * | 2000-12-20 | 2002-07-11 | Auto Tissue Gmbh | Verfahren zur Dezellularisierung von Fremdmaterial zur Herstellung von Bioprothesen und Vorrichtung zur Durchführung des Verfahrens |
US20040166170A1 (en) * | 2003-02-26 | 2004-08-26 | Hunter Gary L. | Method for therapeutically treating mammals |
US20150352145A1 (en) * | 2006-01-18 | 2015-12-10 | CorMartix Cardiovascular, Inc. | Method and System for Treatment of Damaged Biological Tissue |
KR100903030B1 (ko) * | 2007-08-23 | 2009-06-18 | 주식회사 안지오랩 | 멜리사엽 추출물 분획 및 이를 포함하는 조성물 |
US20090163990A1 (en) * | 2007-12-19 | 2009-06-25 | Chunlin Yang | Decellularized omentum matrix and uses thereof |
WO2011041478A1 (en) * | 2009-10-02 | 2011-04-07 | Baxter International Inc. | Hematopoietic stem cells for use in the treatment of a kidney injury |
RU2674153C2 (ru) | 2012-01-05 | 2018-12-05 | Бостон Медикал Сентер Корпорэйшн | Slit-robo сигналинг для диагностики и лечения заболевания почек |
EP3013380B1 (en) * | 2013-06-24 | 2022-11-23 | Ramot at Tel-Aviv University Ltd. | Omentum based scaffold and delivery system |
EP3641811A4 (en) * | 2017-06-21 | 2021-03-31 | Timothy A. Bertram | IMMUNPRIVILEGATED BIOACTIVE KIDNEY CELLS FOR TREATMENT OF KIDNEY DISEASE |
AU2018405440A1 (en) * | 2018-01-31 | 2020-08-27 | Rokit Healthcare Inc. | Bioink composition for dermis regeneration sheet, method for manufacturing customized dermis regeneration sheet using same, and customized dermis regeneration sheet manufactured using manufacturing method |
KR102188316B1 (ko) | 2018-11-30 | 2020-12-08 | 주식회사 케이엔알 | 센서형 크로마토그래프 분석장치 |
-
2021
- 2021-04-09 WO PCT/KR2021/004497 patent/WO2021241880A1/ko unknown
- 2021-04-09 CN CN202180002778.4A patent/CN114258304A/zh active Pending
- 2021-04-09 US US17/442,027 patent/US20230072749A1/en active Pending
- 2021-04-09 BR BR112022024233A patent/BR112022024233A2/pt unknown
- 2021-04-09 KR KR1020210046267A patent/KR102311441B1/ko active IP Right Grant
- 2021-04-09 JP JP2022573385A patent/JP2023527435A/ja active Pending
- 2021-04-09 EP EP21766372.3A patent/EP3998090A4/en active Pending
- 2021-09-29 KR KR1020210128587A patent/KR20210147998A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2021241880A1 (ko) | 2021-12-02 |
KR20210147998A (ko) | 2021-12-07 |
KR102311441B1 (ko) | 2021-10-13 |
US20230072749A1 (en) | 2023-03-09 |
EP3998090A4 (en) | 2023-08-02 |
CN114258304A (zh) | 2022-03-29 |
EP3998090A1 (en) | 2022-05-18 |
JP2023527435A (ja) | 2023-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018074591A2 (pt) | métodos de fabricação de uma película à base de plasma flexível, e películas à base de plasma flexível | |
BR112014005132A2 (pt) | curativo e dispositivo para utilização na terapia de ferimentos por pressão negativa, instrumento cirúrgico para aplicação de um curativo, kit para o tratamento de ferimentos com pressão negativa | |
CO2019001236A2 (es) | Compuestos y métodos para la modulación de smn2 | |
BR112017019413A2 (pt) | combinação de agente bactericida com um agente alcalinizante lisossomotrópico para o tratamento de uma infecção bacteriana | |
CL2021003141A1 (es) | Uso de una composición para el cuidado bucal. | |
BR112016024176A2 (pt) | composições para tratamento bucal tendo estabilidade aprimorada | |
CO2022010242A2 (es) | Formas farmacéuticas sólidas que contienen bacterias y vesículas extracelulares microbianas | |
BR112017004153A2 (pt) | métodos para tratamento de infecções por protozoários | |
CL2008002356A1 (es) | Sulfoxidos de piperazina-amida; sus procesos de preparacion; las composiciones farmaceuticas que los contienen; y su uso en el tratamiento de enfermedades que se modulan con agonistas lxr alfa y/o beta. | |
BR112017011883A2 (pt) | composição de organosiloxano com alto índice de refração e aplicações contendo a mesma | |
BR112012027092A2 (pt) | métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal | |
BR112018008544A2 (pt) | composição de formação de película dental durável e usos da mesma | |
BR112013000706A2 (pt) | reforço tendo uma estrutura de três camadas e emplastro aquoso usando o reforço | |
BR112022008484A2 (pt) | Método de tratamento de anemia, método para aumentar os níveis de hemoglobina em um paciente com anemia associada ou secundária à doença renal crônica e método para manter ou controlar os níveis de hemoglobina em um paciente com anemia associada ou secundária à doença renal crônica | |
BR112022024233A2 (pt) | Composição de tratamento renal usando omento, kit médico de tratamento renal que compreende a mesma e filme de tratamento renal que compreende produto curado da mesma | |
BR112017014189A2 (pt) | terapia de câncer com um parvovirus combinado com bevacizumabe | |
BR112015022571A2 (pt) | método de tratamento de esteatose hepática | |
CL2021000444A1 (es) | Métodos para reducir el riesgo de diabetes en pacientes tratados por enfermedades relacionadas con el colesterol alto. | |
BR112021025665A2 (pt) | Uma preparação que compreende um composto de calixareno e o uso médico do mesmo, alimento, ração ou composição cosmética que compreende um composto de calixareno | |
UY31548A1 (es) | Derivados de azetidinas, su preparacion y su aplicacion en terapéutica | |
CL2022001079A1 (es) | Métodos y composiciones para el tratamiento del síndrome de rett | |
BR112019017314A2 (pt) | composições farmacêuticas para terapia de combinação | |
NZ756307A (en) | Formulations of cannabinoids for the treatment of acne | |
BR112022019403A2 (pt) | Uso de um derivado de tienopiridona no tratamento de doença renal policística autossômica dominante (drpad) | |
BR112018008835A8 (pt) | composição farmacêutica oral, composição farmacêutica de liberação pulsátil oral, método para tratar uma condição de doença que requer terapia com fumarato de dimetila e método para tratar esclerose múltipla |